Alterity Therapeutics Limited (ATHE:NASDAQ) soared at $1.04, representing a gain of 32.2%. From Wed 27 Nov 19, the stock recorded 21.43% Up Days and 20.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Alterity Therapeutics Limited (ATHE:NASDAQ)
Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Top 10 Gainers:
- Catalyst Biosciences, Inc. (CBIO:NASDAQ), 65.83%
- Southwest Georgia Financial Corporation (SGB:NYSEMKT), 48.25%
- Zion Oil & Gas, Inc. (ZN:NASDAQ), 46.38%
- Selecta Biosciences, Inc. (SELB:NASDAQ), 45.21%
- Rite Aid Corporation (RAD:NYSE), 42.31%
- PLx Pharma Inc. (PLXP:NASDAQ), 41.37%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 37.5%
- ENDRA Life Sciences Inc. (NDRA:NASDAQ), 35.92%
- Estre Ambiental, Inc. (ESTR:NASDAQ), 34.48%
- Alterity Therapeutics Limited (ATHE:NASDAQ), 32.24%